Qube Research & Technologies (QRT)’s Soleno Therapeutics SLNO Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-483,884	Closed	-$16.2M	–	4018
2026 Q1	$16.2M	Buy	483,884 +196,591	+68%	+$7.71M	0.02%	1001
2025 Q4	$13.3M	Buy	287,293 +221,521	+337%	+$12.1M	0.01%	1154
2025 Q3	$4.45M	Sell	65,772 -51,102	-44%	-$3.79M	﹤0.01%	1825
2025 Q2	$9.79M	Sell	116,874 -106,413	-48%	-$7.96M	0.01%	1303
2025 Q1	$16M	Buy	223,287 +104,673	+88%	+$5.1M	0.02%	864
2024 Q4	$5.33M	Buy	118,614 +95,494	+413%	+$4.95M	0.01%	1457
2024 Q3	$1.17M	Sell	23,120 -33,196	-59%	-$1.59M	﹤0.01%	1972
2024 Q2	$2.3M	Sell	56,316 -22,184	-28%	-$940K	﹤0.01%	1560
2024 Q1	$3.36M	Buy	78,500 +59,804	+320%	+$2.71M	0.01%	1456
2023 Q4	$753K	Buy	+18,696	New	+$532K	﹤0.01%	2078

Qube Research & Technologies (QRT)'s SLNO Position: Q2 2026 in Review

Qube Research & Technologies (QRT) sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 483,884 shares — an estimated $16.2M sold.

Qube Research & Technologies (QRT) first reported a position in SLNO in Q4 2023 and held it in 10 quarters. The position peaked at $16.2M in Q1 2026. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

Qube Research & Technologies (QRT) reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 483,884 Soleno Therapeutics shares in Q2 2026, an estimated $16.2M.
Qube Research & Technologies (QRT) first reported a position in Soleno Therapeutics in Q4 2023 and held it in 10 quarters.
Qube Research & Technologies (QRT)'s Soleno Therapeutics position peaked at $16.2M in Q1 2026.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.